The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
NCT04942860
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Non-segmental Vitiligo
Interventions
DRUG:
1% Methotrexate gel
DRUG:
0.5% Methotrexate gel
Sponsor
Nicolaus Copernicus University